Matthew P. Young
Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Matthew P. Young
Matthew P. Young is recorded as CFO at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $3,583,378 for Matthew P. Young in fiscal 2019, including a base salary of $601,253. Disclosed compensation is on record for 3 fiscal years. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $601,253 | $3,583,378 |
| 2018 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $575,385 | $3,356,337 |
| 2017 | Jazz Pharmaceuticals plc (JAZZ) | Former Executive Vice President and CFO | $545,385 | $3,292,653 |
Recent activity
No call appearances or filed executive changes recorded yet.